Kennedy, R.C., J.W.Eichberg, and G.R.Dreesman. 1985. Internal image anti-idiotypic antibodies as a vaccine for hepatitis B virus. Paper presented at a meeting on Modern Approaches to Vaccines, Cold Spring Harbor Laboratories, Cold Spring Harbor, N.Y., Sept. 11–15, 1985.
Lerner, R.A., N.Green, H.Alexander, F.T.Liu, J.G.Sutcliffe, and T.M.Shinnick. 1981. Chemically synthesized peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicit antibodies reactive with the native envelope protein in Dane particles. Proc. Natl. Acad. Sci. USA 78(6):3403–3407.
Maupas, P., and J.L.Melnick. 1981. Hepatitis B infection and primary liver cancer. Prog. Med. Virol. 27.
McAleer, W.J., E.B.Buynak, R.Z.Maigetter, D.E.Wampler, W.J.Miller, and M.R.Hilleman. 1984. Human hepatitis B vaccine from recombinant yeast. Nature 307(5947):178–180.
McAuliffe, V.J., R.H.Purcell, J.L.Gerin, and F.J.Tyeryar. 1982. Current status of the NIAID hepatitis B vaccines. Pp. 425–435 in Viral Hepatitis: 1981 International Symposium, W.Szmuness, H.J. Alter, and J.E.Maynard, eds. Philadelphia: The Franklin Institute.
Miyanohara, A., A.Toh-e, C.Nozaki, F.Hamada, N.Ohtomo, and K. Matsubara. 1983. Expression of hepatitis B surface antigen gene in yeast. Proc. Natl. Acad. Sci. USA 80(1):1–5.
National Institute of Allergy and Infectious Diseases. 1985. Program in Accelerated Development of New Vaccines. Progress Report. Bethesda, Md.: National Institutes of Health.
Paoletti, E. 1984. Hepatitis B virus and herpes simplex virus. Paper presented at a Workshop on Vaccinia Viruses as Vectors for Vaccine Antigens, Chevy Chase, Md., Nov. 13–14, 1984. Sponsored by the U.S. Public Health Service, the World Health Organization, and the National Institute of Biological Standards.
Patzer, E.J., G.R.Nakamura, and A.Yaffe. 1984. Intracellular transport and secretion of hepatitis B surface antigen in mammalian cells. J.Virol. 51:346–353.
Robinson, W.S. 1978. Hepatitis B Dane particle DNA structure and the mechanism of the endogenous DNA polymerase reaction. Pp. 139–145in Viral Hepatitis: A Contemporary Assessment of Etiology, Epidemiology, Pathogenesis and Prevention, G.N.Vyas, S.N.Cohen, and R.Schmid, eds. Philadelphia: The Franklin Institute.
Schweitzer, I.L., J.W.Mosley, M.Aschavai, V.M.Edwards, and L.V. Overby. 1973. Factors influencing neonatal infection by hepatitis B virus. Gastroenterology 65(2):277–283.
Scolnick, E.M., A.A.McLean, D.J.West, W.J.McAleer, W.J.Miller, and E.B.Buynak. 1984. Clinical evaluation in healthy adults of a hepatitis B vaccine made by recombinant DNA. JAMA 251(21):2812–2815.
Smith, G. 1984. Hepatitis B virus and malaria. Paper presented at a Workshop on Vaccinia viruses as Vectors for Vaccine Antigens, Chevy Chase, Md., Nov. 13–14, 1984. Sponsored by the U.S. Public Health Service, the World Health Organization, and the National Institute of Biological Standards.